Verzenio price:
The cost
of Verzenio (abemaciclib) can vary widely depending on several factors,
including the patient's location, insurance coverage, and the dosage and
duration of treatment. As of February 2023, the list price for a 28-day supply
of Verzenio ranges from approximately $13,000 to $16,000 in the United States,
according to the manufacturer's website.
However,
it is important to note that many patients may not pay the full list price for Verzenio
due to insurance coverage, government programs, and other factors. The cost of
Verzenio can also vary widely depending on the patient's insurance coverage and
out-of-pocket expenses.
Some
patients may be eligible for financial assistance to help cover the cost of
Verzenio. The manufacturer of Verzenio offers a program called Verzenio Access
Connect, which provides support services for patients who are prescribed the
medication. This program can help patients navigate insurance coverage and
other financial issues, and it may be able to help patients access financial
assistance programs to help cover the cost of the medication.
In
addition, some patients may be eligible for assistance through government
programs such as Medicare or Medicaid. These programs can help cover the cost
of Verzenio for eligible patients, although the specific coverage and
eligibility requirements may vary depending on the patient's location and
medical history.
It is
important to note that the cost of cancer treatment can be a significant
financial burden for many patients and their families, and it is important to
work closely with healthcare providers, insurance companies, and financial
assistance programs to manage the cost of treatment.
If you
are prescribed Verzenio or any other cancer medication, it is important to
discuss the cost of treatment with your healthcare team and explore all
available options for financial assistance and support. With the right
resources and support, many patients are able to access the medications and
treatments they need to manage their cancer and improve their quality of life.
0 Comments